New implant aims to ease stubborn back pain without major surgery

NCT ID NCT07558278

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a new device called the LINQ system, which is implanted through a small incision to fuse the sacroiliac joint. It compares the procedure to standard non-surgical treatments like medication and physical therapy. The trial will enroll 200 adults with chronic sacroiliac joint pain that hasn't responded to other treatments. The main goal is to see if the device provides better pain relief and safety over six months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

LINQ system (bone allograft implant for sacroiliac fusion)

What this could lead to

If successful, this could offer a minimally invasive surgical option for people with chronic sacroiliac joint pain that hasn't improved with other treatments.

What could go wrong

This is a phase 4 trial, but it hasn't started recruiting yet. The surgery carries risks like infection or device problems, and it may not work better than non-surgical care.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SACROILIAC JOINT PAIN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••